Author: Ye, Fuqiang; Han, Yifang; Zhu, Juanjuan; Li, Peng; Zhang, Qi; Lin, Yanfeng; Wang, Taiwu; Lv, Heng; Wang, Changjun; Wang, Chunhui; Zhang, Jinhai
Title: First Identification of Human Adenovirus Subtype 21a in China With MinION and Illumina Sequencers Document date: 2020_4_7
ID: 18b2foud_53
Snippet: Nanopore sequencing technology has an advantage of extremely long-read output (>2.3 Mb according to ONT website) over current NGS platforms. This characteristic has promoted rapid identification of pathogens in the field (McIntyre et al., 2016; Castro-Wallace et al., 2017; Johnson et al., 2017; Edwards et al., 2019) , especially for bacteria and viruses. Human adenoviruses usually have 35-36 kb in their genomes, which could be captured and covere.....
Document: Nanopore sequencing technology has an advantage of extremely long-read output (>2.3 Mb according to ONT website) over current NGS platforms. This characteristic has promoted rapid identification of pathogens in the field (McIntyre et al., 2016; Castro-Wallace et al., 2017; Johnson et al., 2017; Edwards et al., 2019) , especially for bacteria and viruses. Human adenoviruses usually have 35-36 kb in their genomes, which could be captured and covered by ONT with a single read. There were 21 MinION reads longer than 30 kb, 20 of which could be identified as HAdV21a with a genome coverage ≥82.27%. These reads were produced in 54 min to ∼15.5 h after the start of sequencing, with eight (40%) generated in ≤2.5 h. This demonstrated the feasibility of nanopore technology in the rapid detection of HAdV, thus providing key information for disease control and treatment.
Search related documents:
Co phrase search for related documents- disease control and human adenovirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- disease control and key information: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- disease control and long read: 1
- disease control and Nanopore sequencing technology: 1
- disease control and nanopore technology: 1
- disease control and pathogen rapid identification: 1, 2
- disease control and rapid detection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- disease control and rapid identification: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- disease control and sequencing start: 1
- disease control and sequencing technology: 1, 2, 3, 4
- disease control and single read: 1
- disease control and treatment disease control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- disease control and virus bacteria: 1, 2, 3, 4, 5, 6
- genome coverage and long read: 1, 2, 3, 4, 5, 6, 7, 8, 9
- genome coverage and Nanopore sequencing technology: 1
- genome coverage and nanopore technology: 1, 2
- genome coverage and NGS platform: 1
- genome coverage and rapid identification: 1
- genome coverage and sequencing technology: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Co phrase search for related documents, hyperlinks ordered by date